Eduardo Méndez

2.6k total citations
50 papers, 1.9k citations indexed

About

Eduardo Méndez is a scholar working on Otorhinolaryngology, Molecular Biology and Surgery. According to data from OpenAlex, Eduardo Méndez has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Otorhinolaryngology, 21 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Eduardo Méndez's work include Head and Neck Cancer Studies (25 papers), Head and Neck Surgical Oncology (8 papers) and Cancer-related gene regulation (7 papers). Eduardo Méndez is often cited by papers focused on Head and Neck Cancer Studies (25 papers), Head and Neck Surgical Oncology (8 papers) and Cancer-related gene regulation (7 papers). Eduardo Méndez collaborates with scholars based in United States, South Africa and Taiwan. Eduardo Méndez's co-authors include Neal D. Futran, Chu Chen, Stephen M. Schwartz, Melissa P. Upton, Pawadee Lohavanichbutr, D. Gregory Farwell, J. C. Houck, Lue Ping Zhao, Bevan Yueh and Wenhong Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Eduardo Méndez

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo Méndez United States	26	783	722	641	582	378	50	1.9k
Nicholas Kalavrezos United Kingdom	19	570 0.7×	584 0.8×	457 0.7×	490 0.8×	277 0.7×	59	1.7k
M. Gapany United States	22	528 0.7×	652 0.9×	657 1.0×	698 1.2×	370 1.0×	265	1.9k
Annemieke van Zante United States	24	690 0.9×	522 0.7×	721 1.1×	638 1.1×	245 0.6×	71	2.1k
Kolja Freier Germany	30	894 1.1×	684 0.9×	835 1.3×	903 1.6×	440 1.2×	99	2.6k
Sheng‐Po Hao Taiwan	28	394 0.5×	725 1.0×	910 1.4×	683 1.2×	359 0.9×	88	1.9k
Paul Weinberger United States	27	894 1.1×	1.0k 1.4×	838 1.3×	910 1.6×	601 1.6×	80	2.6k
Clóvis Antônio Lopes Pinto Brazil	21	424 0.5×	318 0.4×	484 0.8×	543 0.9×	337 0.9×	116	1.6k
Christof Hofele Germany	24	729 0.9×	409 0.6×	396 0.6×	539 0.9×	244 0.6×	47	1.6k
Theresa Guo United States	23	542 0.7×	490 0.7×	433 0.7×	416 0.7×	182 0.5×	64	1.3k
Jimmy Yu Wai Chan Hong Kong	23	351 0.4×	723 1.0×	807 1.3×	532 0.9×	391 1.0×	70	1.6k

Countries citing papers authored by Eduardo Méndez

Since Specialization

Citations

This map shows the geographic impact of Eduardo Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Méndez more than expected).

Fields of papers citing papers by Eduardo Méndez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Méndez. The network helps show where Eduardo Méndez may publish in the future.

Co-authorship network of co-authors of Eduardo Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Méndez. A scholar is included among the top collaborators of Eduardo Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Méndez. Eduardo Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moser, Russell, Kay E. Gurley, Olga Nikolova, et al.. (2022). Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma. Oncogene. 41(24). 3355–3369. 4 indexed citations

Moser, Russell, James Annis, Olga Nikolova, et al.. (2022). Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL. Cancer Research. 82(18). 3375–3393. 4 indexed citations

Ferris, Robert L., Yael Flamand, Gregory S. Weinstein, et al.. (2020). Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).. Journal of Clinical Oncology. 38(15_suppl). 6500–6500. 68 indexed citations

Diab, Ahmed, et al.. (2019). Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition. Molecular Cancer Research. 17(5). 1115–1128. 27 indexed citations

Méndez, Eduardo, Cristina P. Rodriguez, Michael Kao, et al.. (2018). A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 24(12). 2740–2748. 79 indexed citations

Xu, Chang, Olga Nikolova, Ryan Basom, et al.. (2018). Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clinical Cancer Research. 24(12). 2828–2843. 19 indexed citations

Eadie, Tanya L., Mara R. Kapsner-Smith, Rebecca Hunting Pompon, et al.. (2018). Role of Psychosocial Factors on Communicative Participation among Survivors of Head and Neck Cancer. Otolaryngology. 159(2). 266–273. 13 indexed citations

Méndez, Eduardo, Cristina P. Rodriguez, Michael Kao, et al.. (2017). A phase I clinical trial of AZD1775 in combination with neoadjuvant weekly cisplatin and docetaxel in borderline resectable head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 35(15_suppl). 6034–6034. 2 indexed citations

Li, Shuli, Robert L. Ferris, F. Christopher Holsinger, et al.. (2016). E3311 trial of transoral surgery for oropharynx cancer: Implementation of a novel surgeon credentialing and quality assurance process.. Journal of Clinical Oncology. 34(15_suppl). 6054–6054. 9 indexed citations

10.

Rodriguez, Cristina P., Upendra Parvathaneni, Eduardo Méndez, & Renato Martins. (2015). Salivary Gland Malignancies. Hematology/Oncology Clinics of North America. 29(6). 1145–1157. 4 indexed citations

11.

Mitchell, Ryan M., Eduardo Méndez, Nicole C. Schmitt, Amit D. Bhrany, & Neal D. Futran. (2015). Antibiotic Prophylaxis in Patients Undergoing Head and Neck Free Flap Reconstruction. JAMA Otolaryngology–Head & Neck Surgery. 141(12). 1096–1096. 60 indexed citations

12.

Moser, Russell, Chang Xu, Michael Kao, et al.. (2014). Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer. Clinical Cancer Research. 20(16). 4274–4288. 66 indexed citations

13.

Bauman, Julie E., Melissa Austin, Brenda F. Kurland, et al.. (2013). ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. British Journal of Cancer. 109(8). 2096–2105. 46 indexed citations

14.

Yueh, Bevan, et al.. (2012). Risk Factors Associated With Repair of Orbital and Lateral Skull Defects. Archives of Facial Plastic Surgery. 14(2). 97–103. 4 indexed citations

15.

Austin, Melissa, Rodney A. Schmidt, Upendra Parvathaneni, et al.. (2012). Expression of p16, ERCC1, and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, and erlotinib: A phase II randomized trial.. Journal of Clinical Oncology. 30(15_suppl). 5515–5515. 6 indexed citations

16.

Lohavanichbutr, Pawadee, J. C. Houck, David R. Doody, et al.. (2012). Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes. PLoS ONE. 7(9). e46575–e46575. 19 indexed citations

17.

Stott‐Miller, Marni, John R. Houck, Pawadee Lohavanichbutr, et al.. (2011). Tumor and Salivary Matrix Metalloproteinase Levels Are Strong Diagnostic Markers of Oral Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 20(12). 2628–2636. 69 indexed citations

18.

Xu, Chang, Yan Liu, Pei Wang, et al.. (2010). Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Molecular Cancer. 9(1). 143–143. 49 indexed citations

19.

Choi, Peter, C. Diana Jordan, Eduardo Méndez, et al.. (2008). Examination of Oral Cancer Biomarkers by Tissue Microarray Analysis. Archives of Otolaryngology - Head and Neck Surgery. 134(5). 539–539. 55 indexed citations

20.

Futran, Neal D. & Eduardo Méndez. (2006). Developments in reconstruction of midface and maxilla. The Lancet Oncology. 7(3). 249–258. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact